Filene Research Institute – Trademark Portfolio
Entity Type: 03
Filene Research Institute holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include FILENE I3 and FILENE * I3. The owner is based in Madison, WI.
1010 E. Washington Ave., Suite 306
Madison, WI 53703
Showing of trademarks Trademarks
Trademark Classifications
Filene Research Institute's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Filene Research Institute have?
Filene Research Institute has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Filene Research Institute file in?
Filene Research Institute files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are Filene Research Institute's most well-known trademarks?
Filene Research Institute's registered trademark portfolio includes well-known marks such as FILENE I3 and FILENE * I3. These are among 2 currently registered trademarks in the portfolio.
What is Filene Research Institute's trademark registration success rate?
Filene Research Institute has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.